Utilisation and Outcomes of Eribulin in Triple-Negative Metastatic Breast Cancer (TN MBC): Real-World Findings

被引：0
|
作者：
Kish, Jonathan K. [1 ]
Mougalian, Sarah S. [2 ]
Copher, Ronda [3 ]
McAllister, Lindsay [1 ]
Wang, Zhixiao [3 ]
Janevski, Mile [4 ]
Broscious, Mary [1 ]
机构：
[1] Cardinal Hlth Specialty Solut, Dublin, OH USA
[2] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
[4] Eisai Australia, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
168
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Imaging findings of triple-negative breast cancer
    Hiroko Kawashima
    Breast Cancer, 2011, 18 : 145 - 145
  • [42] Imaging findings of triple-negative breast cancer
    Kawashima, Hiroko
    BREAST CANCER, 2011, 18 (03) : 145 - 145
  • [43] Outcomes of real-world use of eribulin plus trastuzumab for HER2-positive metastatic breast cancer
    Mougalian, S. S.
    Copher, R.
    McAllister, L.
    Radtchenko, J.
    Wang, E. C.
    Broscious, M.
    Yu, H-T
    Kish, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [44] EFFICACY AND SAFETY OF ERIBULIN IN PATIENTS WITH TRIPLE NEGATIVE METASTATIC BREAST CANCER: REAL LIFE EXPERIENCE
    Valentinova, Ludmila Manzyuk
    BREAST, 2017, 36 : S57 - S58
  • [45] Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort
    Grinda, Thomas
    Antoine, Alison
    Jacot, William
    Cottu, Paul-Henri
    Rouge, Thibault de la Motte
    Frenel, Jean-Sebastien
    Mailliez, Audrey
    Dalenc, Florence
    Goncalves, Anthony
    Clatot, Florian
    Reynier, Marie-Ange Mouret
    Levy, Christelle
    Ferrero, Jean-Marc
    Desmoulins, Isabelle
    Uwer, Lionel
    Petit, Thierry
    Jouannaud, Christelle
    Arnedos, Monica
    Chevrot, Michael
    Courtinard, Coralie
    Tredan, Olivier
    Brain, Etienne
    Perol, David
    Pistilli, Barbara
    Delaloge, Suzette
    EUROPEAN JOURNAL OF CANCER, 2023, 189
  • [46] Clinical outcome of triple-negative (TN) breast cancer (BC)
    Cabuk, D.
    Basaran, G.
    Kaya, H.
    Gulluoglu, B.
    Teomete, M.
    Dane, F.
    Yumuk, P. F.
    Turhal, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Efficacy and safety of eribulin in patients with triple negative metastatic breast cancer: real life experience
    Manikhas, A.
    Gorbunova, V.
    Manzyuk, L.
    Kovalenko, E.
    Bolotina, L.
    Zhukova, L.
    Vladimirova, L.
    Kolyadina, I.
    Ponomarenko, D.
    Mukhametshina, G.
    BREAST, 2019, 44 : S61 - S62
  • [48] Eribulin in heavily pretreated metastatic breast cancer: A real-world data from India
    Mandal, T. K.
    Bajpai, J.
    Kapoor, A.
    Kumar, A.
    Ghosh, J.
    Gulia, S.
    Rath, S.
    Gupta, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1264 - S1264
  • [49] Aspire to ASCENT: Real-world outcomes from patients with metastatic triple-negative breast cancer (mTNBC) treated with Sacituzumab govitecan (Saci) in a single academic institution
    Walsh, E. M.
    Klar, M.
    Abuhadra, N.
    Robson, M.
    Drago, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S359 - S359
  • [50] Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer
    Chabot, Isabelle
    Zhao, Qi
    Su, Yun
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (12) : 2025 - 2036
12345